All products

5-Amino-1MQ

MXC 5-Amino-1MQ 150 mg vial

Size

Research focus

A methylquinolinium compound associated with research on inhibitors of nicotinamide N-methyltransferase (NNMT).

In simple words

5-Amino-1MQ is a methylquinolinium small molecule associated with research on NNMT, an enzyme involved in cellular metabolism. 5-Amino-1MQ is not a peptide; the selected inhibitor-series study does not verify this vial’s exact salt, structure or contents.

The cited abstract describes an inhibitor series. It does not verify the exact salt, structure or contents of this catalogue product.

Research references

Reviewed 2026-10-26

Methylquinolinium NNMT inhibitors

Preclinical — cells and mice

Cultured adipocytes and diet-induced-obese mice; counts not stated in the reviewed abstract.

A series of NNMT inhibitors was studied for selectivity and cellular metabolism. A potent inhibitor reduced weight and adipose measures in the mouse model.

The abstract discusses a compound series, not verified contents of this vial. No human efficacy or long-term safety follows from these experiments. Full-text verification of the exact catalogue salt/form was unavailable.

PMID 29155147. Indexed abstract checked through Europe PMC on 2026-10-26. Selected evidence, not a systematic review.

Resources

Identity search; no unambiguous compound record assigned to this listing. Check forms and synonyms carefully.

PubChem

Mechanism and target search. Automated access returned 403; DrugBank was not used to substantiate claims or approval status.

DrugBank

Protein/precursor search, not a record of the supplied vial. Synthetic compounds and lab supplies may have no matching protein entry.

UniProt

Bioactivity search. Assay results depend on the tested compound, target and experimental conditions.

ChEMBL

Explore indexed literature. Search results are not supporting citations; selected verified publications appear above.

PubMed

Explore registrations. A match or completed study does not establish efficacy, approval or relevance to this vial.

ClinicalTrials.gov

Evidence on studied compounds does not establish the identity, purity, safety, or regulatory approval of the catalogue vial. No Canadian regulatory status is assessed here.

Research questions about 5-Amino-1MQ

What is 5-Amino-1MQ?

5-Amino-1MQ is a methylquinolinium small molecule associated with research on NNMT, an enzyme involved in cellular metabolism. 5-Amino-1MQ is not a peptide; the selected inhibitor-series study does not verify this vial’s exact salt, structure or contents.

What types of research are cited for 5-Amino-1MQ?

The 5-Amino-1MQ profile contains the following selected evidence. This is not a systematic review or a complete inventory of research.

Methylquinolinium NNMT inhibitors (2018): Preclinical — cells and mice

Publication: Methylquinolinium NNMT inhibitors
Who or what was studied in the selected 5-Amino-1MQ references?

Methylquinolinium NNMT inhibitors (2018): Cultured adipocytes and diet-induced-obese mice; counts not stated in the reviewed abstract.

Publication: Methylquinolinium NNMT inhibitors
What identity distinctions matter for 5-Amino-1MQ?

The cited abstract describes an inhibitor series. It does not verify the exact salt, structure or contents of this catalogue product.

What do the selected 5-Amino-1MQ studies not establish?

Methylquinolinium NNMT inhibitors (2018): The abstract discusses a compound series, not verified contents of this vial. No human efficacy or long-term safety follows from these experiments. Full-text verification of the exact catalogue salt/form was unavailable.

Publication: Methylquinolinium NNMT inhibitors

These studies do not establish the identity, purity, safety or effects of the MXC 5-Amino-1MQ vial. Findings in one formulation, population or experimental model should not be assumed to apply to another.